1. Home
  2. PMAX vs ENSC Comparison

PMAX vs ENSC Comparison

Compare PMAX & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • ENSC
  • Stock Information
  • Founded
  • PMAX 2019
  • ENSC 2003
  • Country
  • PMAX Hong Kong
  • ENSC United States
  • Employees
  • PMAX N/A
  • ENSC N/A
  • Industry
  • PMAX
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMAX
  • ENSC Health Care
  • Exchange
  • PMAX Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • PMAX 6.6M
  • ENSC 5.5M
  • IPO Year
  • PMAX 2024
  • ENSC N/A
  • Fundamental
  • Price
  • PMAX $0.45
  • ENSC $2.64
  • Analyst Decision
  • PMAX
  • ENSC
  • Analyst Count
  • PMAX 0
  • ENSC 0
  • Target Price
  • PMAX N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • PMAX 820.9K
  • ENSC 24.9K
  • Earning Date
  • PMAX 04-15-2025
  • ENSC 05-12-2025
  • Dividend Yield
  • PMAX N/A
  • ENSC N/A
  • EPS Growth
  • PMAX N/A
  • ENSC N/A
  • EPS
  • PMAX 0.04
  • ENSC N/A
  • Revenue
  • PMAX $5,970,263.00
  • ENSC $5,210,031.00
  • Revenue This Year
  • PMAX N/A
  • ENSC N/A
  • Revenue Next Year
  • PMAX N/A
  • ENSC N/A
  • P/E Ratio
  • PMAX $8.96
  • ENSC N/A
  • Revenue Growth
  • PMAX 30.05
  • ENSC 133.58
  • 52 Week Low
  • PMAX $0.28
  • ENSC $2.12
  • 52 Week High
  • PMAX $4.70
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • ENSC 23.45
  • Support Level
  • PMAX N/A
  • ENSC $3.30
  • Resistance Level
  • PMAX N/A
  • ENSC $3.58
  • Average True Range (ATR)
  • PMAX 0.00
  • ENSC 0.32
  • MACD
  • PMAX 0.00
  • ENSC -0.05
  • Stochastic Oscillator
  • PMAX 0.00
  • ENSC 22.21

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: